Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Bliss GVS Pharma

Sector: Healthcare | Industry: Drugs & Pharma
R 135.20 7.00  | 5.46% -19.64% 11.77 1,402.28
NSE Price: Oct 22, 15:57 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 22, 15:57 135.20 7.00 5.46% 130.00 128.20 287,472 130.00 - 141.80
BSE Oct 22, 2019 135.95 8.90 7.01% 132.85 127.05 87,072 129.90 - 141.70
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 924,158 P/B: 2.06 NSE Code: BLISSGVS
52-Week Range: R 73.75 - 185.70 Dividend Yield: 0.74% BSE Code: 506197
TTM EPS: R 11.56 Book Value: R 65.86 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 38 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Bliss GVS Pharma -18.13 30.22 -12.46 -19.22 -4.74 18.08 16.50
S&P BSE Small Cap -10.31 -0.11 0.26 -4.45 -0.60 4.66 5.60
S&P BSE Healthcare -7.84 -1.42 0.06 -11.61 -7.74 -1.50 11.51
Company's return has been calculated on basis of BSE's price.
As on Oct 22, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 10.26 17.99 21.12
Net Profit 42.86 8.14 25.29
EPS 110.46 14.47 24.72
Book Value 20.47 16.12 17.74
Average
Operating Margin 21.74 25.38 27.89
Net Margin 13.53 12.66 13.97
Return on Networth 21.43 21.28 22.06
Return on Investment 26.58 27.42 27.58
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -13.32 3.02 -13.32
Operating Profit 47.06 -6.30 47.06
Net Profit 77.61 -14.40 77.61
EPS 86.61 -11.82 86.61
TTM
Revenue 0.69 13.78 0.69
Operating Profit -1.76 -8.90 -1.76
Net Profit -4.43 33.40 -4.43
EPS -3.66 57.01 -3.66
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Bliss GVS Pharma 1,402.28 904.45 121.05 13.01 21.43 2.06 11.77
Astrazeneca Pharma India 6,030.25 771.42 69.56 8.84 20.03 18.83 86.69
Eris Lifesciences 5,850.09 1,005.70 303.64 29.29 28.96 4.74 19.27
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Mar 08, 2019 Arjun Gautam Ashra  Buy Inter-Se Transfer 49,000 171.25 83.91
Mar 08, 2019 Gautam Rasiklal Ashra  Sell Inter-Se Transfer 49,000 171.25 83.91
Feb 01, 2019 Antara Gautam Ashra  Sell Market 1,647,924 144.30 2,377.95
Feb 01, 2019 Antara Gautam Ashra  Sell Market 1,647,924 144.30 2,377.95
Feb 01, 2019 Gautam Rasiklal Ashra  Sell Market 1,861,743 144.30 2,686.50
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Motilal Oswal Mutual Fund 0.002 - - - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Bliss GVS Pharma Ltd.

Address: 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai, Maharashtra - 400072 | Phone: 022-42160000 | Fax: 022-28563930

Email: [email protected]

Website: www.blissgvs.com

Registrar & Transfer Agent: Universal Capital Securities Pvt. Ltd

Address: (Formerly Mondkar Computers Pvt Ltd), 21 Shakil Niwas , Opp. Satya Saibaba Temple,Mahakali Caves Road,Andheri (E),Mumbai, (Formerly Mondkar Computers Pvt Ltd), 21 Shakil Niwas, Opp. Satya Saibaba Temple, Mahakali Caves Road, Andheri (E) | Phone: 022-28366620/28257641 | Fax: 022-28366620

Email: [email protected]

Essential checks
Altman Z-Score
6.73
Piotroski F-Score
7
Modified C-Score
6
5-Years Price to Earnings
11.77
5-Years Price to Book
2.06
Earnings Yield
EBIT / Enterprise value
13.05%
PEG
Price / Earnings to growth ratio
0.60
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,412.00 +5.87%
Caplin Point Laboratories R387.75 -2.29%
Eris Lifesciences R425.40 +0.66%
FDC R160.95 +0.03%
JB Chemicals & Pharma R359.80 -1.84%
Laurus Labs R341.70 +8.06%
Strides Pharma Science R350.75 -0.88%
Sun Pharma Adv. Research R132.60 +0.08%
Suven Life Sciences R286.65 +2.17%
Wockhardt R275.20 +3.28%
As on Oct 22, 15:59